PHILADELPHIA, PA / ACCESSWIRE / December 11, 2019 / Hoth Therapeutics, Inc. (NASDAQ:HOTH), will be presenting at this year’s Investor Summit on December 17th in Philadelphia.
The Investor Summit will take place at Hotel Monaco, featuring 30 companies and over 200 institutional and retail investors.
About Hoth Therapeutics, Inc.
Hoth Therapeutics is a development-stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema.
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors.
To register as a presenting company please email info@microcapconf.com.
To request complimentary investor registration: please visit our website at www.microcapconf.com.
News Compliments of ACCESSWIRE
FOR MORE INFORMATION
Please visit: www.microcapconf.com
Or, contact Ashley Allard at ashley@microcapconf.com
SOURCE: Hoth Therapeutics
View source version on accesswire.com:
https://www.accesswire.com/569873/Hoth-Therapeutics-Inc-to-Present-at-the-Investor-Summit-on-December-17th-in-Philadelphia
CHICAGO, Dec. 16, 2025 /PRNewswire/ -- ABMS AssessLink®, a leading provider of test development and…
CHICAGO, Dec. 16, 2025 /PRNewswire/ -- ABMS AssessLink®, a leading provider of test development and…
WEST DES MOINES, Iowa, Dec. 16, 2025 /PRNewswire/ -- Navigate Wellbeing Solutions announced today the expansion…
WEST DES MOINES, Iowa, Dec. 16, 2025 /PRNewswire/ -- Navigate Wellbeing Solutions announced today the expansion…
Manufacturing Growth Expected in 2026; Revenue to Increase 4.4%; Capital Expenditures to Increase 3%; Capacity…
Manufacturing Growth Expected in 2026; Revenue to Increase 4.4%; Capital Expenditures to Increase 3%; Capacity…